Reading a Peptide COA
New to certificates of analysis? Start with the broad How to Read a COA guide, then return here for the peptide-specific fields.
What a COA reports, how to interpret each analytical section, and — importantly — what a COA does not tell you.
Direct answer
A Certificate of Analysis (COA) is a document that reports the results of analytical tests performed on a specific batch of material. For a peptide, a COA typically states the identity of the substance, a purity figure (most often from reversed-phase HPLC), and mass spectrometry data supporting the molecular identity, each tied to a batch or lot number. Reading it means checking that the batch number matches the material, understanding which method produced each result, and recognizing the scope of what those methods measure. A COA reports analytical measurements under defined methods; it does not establish that a material is safe, sterile, or suitable for any particular use.
Why this matters
A COA is the primary document through which analytical quality data is communicated for a batch of material. Reading one accurately means separating what the data shows from what it does not — a distinction that is easy to blur. Two people can look at the same "99% purity" figure and draw very different, sometimes unwarranted, conclusions. This page walks through the common sections and the correct, bounded interpretation of each.
The core sections of a peptide COA
COAs vary by laboratory, but most peptide certificates share a common set of fields. The table below shows a representative — not real — layout.
| Field | Example entry | What it reports |
|---|---|---|
| Product / sequence | Example peptide (one-letter sequence) | The substance the certificate describes |
| Batch / lot number | EX-000000 | The specific production run tested |
| Purity (HPLC) | e.g. 99.0% | Relative peak area under the stated HPLC method |
| Identity (MS) | Observed vs theoretical mass | Whether the measured mass matches the expected molecule |
| Appearance | e.g. white lyophilized powder | A visual observation, not a purity measure |
| Test date / method refs | Date; method identifiers | When and how the tests were run |
Purity — usually from HPLC
The purity figure is most often produced by reversed-phase HPLC. In the common area-percent method, the instrument separates the components of the sample and the software calculates the area of the main peak as a percentage of the total integrated area of all detected peaks. A stated purity of 99% means the target peptide accounts for about 99% of the peptide-related material detected under that method, with the remainder attributable to related impurities. Read this figure together with the method that produced it; purity is method-dependent.
Identity — usually from mass spectrometry
Identity data typically comes from mass spectrometry, which measures the mass-to-charge ratio of the molecule; other appropriately specific analytical methods can also support identity. The certificate compares the observed mass against the theoretical mass calculated from the sequence. A match supports the conclusion that the molecule present is the one intended. Mass spectrometry answers a different question than purity: it addresses what the molecule is, not what proportion of the sample it represents.
Batch and lot traceability
Every result on a COA applies to the specific batch tested. The batch or lot number on the certificate should match the number on the material itself. A COA that does not correspond to the batch in hand describes a different production run, and its results do not transfer.
Visual explanation
What a COA supports — and does not establish
What it supports
- The measured purity of a specific batch under a stated analytical method.
- Whether the observed molecular mass matches the intended molecule.
- Traceability of the results to a specific batch or lot.
What it does not establish
- Sterility, endotoxin levels, or microbial content, unless a specific test for those is listed.
- Biological activity, potency, or any functional effect.
- Safety, or suitability or appropriateness for any use, including any use in humans.
Important limitations
A COA reports the results of the specific tests it lists, under the methods it names, for the batch it identifies — and nothing beyond that. A purity figure does not imply sterility; an identity match does not imply activity; none of the standard analytical results address safety or fitness for a purpose. Absence of a test on the certificate means that property was not evaluated, not that it was found acceptable. Different laboratories using different methods or acceptance criteria can report different results for the same material.
Common misconception
"A high purity number on a COA means the material is safe or high quality overall."
Purity is a single, method-specific measurement of relative composition. It says nothing about sterility, endotoxin content, biological activity, or safety. A material can show high chromatographic purity and still not have been tested for any of those other attributes. Quality is a composite of many properties; a COA reports only the ones it explicitly tested.
Related terms
Related Academy lessons
- What Does 99% Peptide Purity Mean?How to read the single most-cited number on a COA.
- What Is HPLC Testing?The method behind most purity figures.
- Purity vs Identity vs PotencyThree distinct properties a COA reports; why they aren't interchangeable.
- What Does a COA Not Establish?The scope limits, in full.
- What Does Third-Party Testing Mean?Independent verification of batch results.
- HPLC vs Mass SpectrometryThe two methods behind purity and identity on a COA.
Further reading & references
- International Union of Pure and Applied Chemistry. "Peptides." IUPAC Compendium of Chemical Terminology (the Gold Book), 5th ed., 2025. https://doi.org/10.1351/goldbook.P04479
- ICH Harmonised Tripartite Guideline. Q6A: Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances (CPMP/ICH/367/96). International Council for Harmonisation. Cited here as an established pharmaceutical analytical/specification framework supporting general principles — quantitative analytical procedures, the role of reference standards, and the separate testing of distinct quality attributes (for example, that sterility is controlled as its own attribute). Note: ICH Q6A governs specifications for new pharmaceutical drug substances and drug products; it is referenced here only to illustrate widely accepted analytical concepts and does not apply to, or govern, research-use-only materials, which are not pharmaceutical drug substances. Available via the ICH guidelines library (ich.org).
Cite this page
Cite this Academy page in your notes or references.
Related research
Practice
Interrogate a sample certificate
Apply this lesson in the interactive COA Laboratory — click each field to see what it may support and what it cannot establish.